| General Information of Drug-Metabolizing Enzyme (DME ID: DME2082) |
| DME Name |
Alpha-galactosidase (melA), Lactobacillus brevis
|
DME Info
|
| UniProt ID |
|
| EC Number |
EC: 3.2.1.22 (Click to Show/Hide the Complete EC Tree)
Hydrolases
Glycosylase
O/S-glycosyl compound glycosidase
EC: 3.2.1.22
|
| Lineage |
Species: Lactobacillus brevis (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilli
Order: Lactobacillales
Family: Lactobacillaceae
Genus: Lactobacillus
Species: Lactobacillus brevis
|
| Interactome |
|
| Interactions between Xenobiotics and DME (XEOTIC)
|
| Amino Acid(s), Peptide(s) or Protein(s) |
|---|
| Peptide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Bacteriocin lacticin Q |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03771
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus brevis |
[1] |
|
|
|
|
|
|
| References |
| 1 |
Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl Environ Microbiol. 2007 May;73(9):2871-7.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
